Scientists coax a deadly bacterium to destroy itself from the inside out

The FDA on Fri­day gave Dai­ichi Sankyo and As­traZeneca’s an­ti­body-drug con­ju­gate En­her­tu a tu­mor-ag­nos­tic in­di­ca­tion un­der ac­cel­er­at­ed ap­proval. It’s the first such ap­proval for a

The partnership will develop advanced cell therapies, involving the engineering of a patient’s T cells to recognise and destroy tumours. Credit: Lightspring / Shutterstock.com. Generate:Biomedicines